84 related articles for article (PubMed ID: 137329)
1. Extraordinary bladder clots.
Keiller DL
J Urol; 1977 Jan; 117(1):43-5. PubMed ID: 137329
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of action of fibrinolytic enzymes in vivo.
Ambrus JL; Weber FJ; Ambrus CM
J Med; 1979; 10(1-2):99-119. PubMed ID: 158624
[TBL] [Abstract][Full Text] [Related]
3. Fibrinolysis and thrombosis of fibrinogen-modified gold nanoparticles for detection of fibrinolytic-related proteins.
Jian JW; Chiu WC; Chang HT; Hsu PH; Huang CC
Anal Chim Acta; 2013 Apr; 774():67-72. PubMed ID: 23567118
[TBL] [Abstract][Full Text] [Related]
4. Activation with plasmin of tow-chain urokinase-type plasminogen activator derived from single-chain urokinase-type plasminogen activator by treatment with thrombin.
Lijnen HR; Van Hoef B; Collen D
Eur J Biochem; 1987 Dec; 169(2):359-64. PubMed ID: 2961562
[TBL] [Abstract][Full Text] [Related]
5. Influence of cider on the fibrinolytic enzyme system.
Anderson JA; Gow LA; Ogston D
Acta Haematol; 1983; 69(5):344-8. PubMed ID: 6220562
[TBL] [Abstract][Full Text] [Related]
6. Sequence of formation of molecular forms of plasminogen and plasmin-inhibitor complexes in plasma activated by urokinase or tissue-type plasminogen activator.
Thorsen S; Müllertz S; Suenson E; Kok P
Biochem J; 1984 Oct; 223(1):179-87. PubMed ID: 6208894
[TBL] [Abstract][Full Text] [Related]
7. Interaction of plasmin with tranexamic acid and alpha 2 plasmin inhibitor in the plasma and clot.
Takada A; Ito T; Takada Y
Thromb Haemost; 1980 Feb; 43(1):20-3. PubMed ID: 6447383
[TBL] [Abstract][Full Text] [Related]
8. [Urokinase does not effect the tissue factor mediated monocyte pro-coagulant activity].
Aref'eva TI; Krasnikova TL
Ross Fiziol Zh Im I M Sechenova; 2000 Oct; 86(10):1308-13. PubMed ID: 11200332
[TBL] [Abstract][Full Text] [Related]
9. Design and evaluation of a thrombin-activable plasminogen activator.
Yang WP; Goldstein J; Procyk R; Matsueda GR; Shaw SY
Biochemistry; 1994 Mar; 33(8):p606-12. PubMed ID: 8117652
[TBL] [Abstract][Full Text] [Related]
10. Urokinase-induced fibrin clot lysis and its inhibition by plasma.
Carlin G
Ups J Med Sci; 1980; 85(1):29-33. PubMed ID: 6446181
[TBL] [Abstract][Full Text] [Related]
11. Biochemical characterization of single-chain chimeric plasminogen activators consisting of a single-chain Fv fragment of a fibrin-specific antibody and single-chain urokinase.
Holvoet P; Laroche Y; Lijnen HR; Van Hoef B; Brouwers E; De Cock F; Lauwereys M; Gansemans Y; Collen D
Eur J Biochem; 1992 Dec; 210(3):945-52. PubMed ID: 1483477
[TBL] [Abstract][Full Text] [Related]
12. Thrombolysis with human extrinsic (tissue-type) plasminogen activator in rabbits with experimental jugular vein thrombosis. Effect of molecular form and dose of activator, age of the thrombus, and route of administration.
Collen D; Stassen JM; Verstraete M
J Clin Invest; 1983 Feb; 71(2):368-76. PubMed ID: 6681615
[TBL] [Abstract][Full Text] [Related]
13. Plasmin-catalyzed proteolysis in colorectal neoplasia.
Delbaldo C; Cunningham M; Vassalli JD; Sappino AP
Cancer Res; 1995 Oct; 55(20):4688-95. PubMed ID: 7553650
[TBL] [Abstract][Full Text] [Related]
14. Photoaffinity labeling of functionally different lysine-binding sites in human plasminogen and plasmin.
Ryan TJ; Keegan MC
Biochim Biophys Acta; 1985 Aug; 830(2):187-94. PubMed ID: 3160389
[TBL] [Abstract][Full Text] [Related]
15. Clot penetration and fibrin binding of amediplase,a chimeric plasminogen activator (K2 tu-PA).
Rijken DC; Barrett-Bergshoeff MM; Jie AF; Criscuoli M; Sakharov DV
Thromb Haemost; 2004 Jan; 91(1):52-60. PubMed ID: 14691568
[TBL] [Abstract][Full Text] [Related]
16. Complementary modes of action of tissue-type plasminogen activator and pro-urokinase by which their synergistic effect on clot lysis may be explained.
Pannell R; Black J; Gurewich V
J Clin Invest; 1988 Mar; 81(3):853-9. PubMed ID: 2963831
[TBL] [Abstract][Full Text] [Related]
17. Urokinase-type plasminogen activator stimulation of monocyte matrix metalloproteinase-1 production is mediated by plasmin-dependent signaling through annexin A2 and inhibited by inactive plasmin.
Zhang Y; Zhou ZH; Bugge TH; Wahl LM
J Immunol; 2007 Sep; 179(5):3297-304. PubMed ID: 17709546
[TBL] [Abstract][Full Text] [Related]
18. Cell-Free DNA Modulates Clot Structure and Impairs Fibrinolysis in Sepsis.
Gould TJ; Vu TT; Stafford AR; Dwivedi DJ; Kim PY; Fox-Robichaud AE; Weitz JI; Liaw PC
Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2544-53. PubMed ID: 26494232
[TBL] [Abstract][Full Text] [Related]
19. Homocysteine and its thiolactone impair plasmin activity induced by urokinase or streptokinase in vitro.
Kolodziejczyk-Czepas J; Talar B; Nowak P; Olas B; Wachowicz B
Int J Biol Macromol; 2012 Apr; 50(3):754-8. PubMed ID: 22197896
[TBL] [Abstract][Full Text] [Related]
20. Plasma fibronectin enhances fibrinolytic system in vitro.
Gilboa N; Kaplan JE
Thromb Haemost; 1985 Oct; 54(3):639-44. PubMed ID: 2935966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
